Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.

Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. Am J Hematol. 2020 06; 95(6):583-593.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Autografts
Bortezomib
Carmustine
Consolidation Chemotherapy
Cyclophosphamide
Etoposide
Female
Humans
Lymphoma, Mantle-Cell
Maintenance Chemotherapy
Male
Middle Aged
Rituximab

authors with profiles

Wendy Stock